Certified by Founder Lodge 
                                        
                                        Alto Neuroscience
 
                                                 United States  -  Los Altos, CA 
                                             START UP 
                                                                                    1 Disclosed Funding Rounds $45,000,000
                                            0 Participating Investments
- 
                                                Founded date 
                                                
2019
 - 
                                                Operating Status 
                                                
Active
 - 
                                                Last Funding Type 
                                                
Seed
 - 
                                                Company Type 
                                                
For Profit
 - Website
 - Contact
 - Social Links
 
                                            Alto Neuroscience is redefining psychiatry by developing personalized and highly effective medicines to help patients get better faster. 
Our artificial intelligence (AI)-enabled platform
                                        
                                        
                                        
                                                                                
                                        
                                                                                | Date | Round | Raised | Participating Investors | 
|---|---|---|---|
| November, 22 ,2023 | Series C | $45,000,000 | 
                                                
 Alkeon Capital Management
                                                                                
 Alpha Wave Global, LP
                                                                                
 What If Ventures
                                                                                
 Eli Lilly and Company
                                                                                
 Alexandria Real Estate Equities, Inc.
                                                                                
 Windham Venture Partners
                                                                                
 Franklin Templeton
                                                                                
 Point72
                                                                                
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
                                                                        
                                Helex |  $3,500,000  | (Nov 4, 2025)
                                                                        
                                xMEMS |  $21,000,000  | (Nov 4, 2025)
                                                                        
                                catalyx space |  $5,400,000  | (Nov 4, 2025)
                                                                        
                                Cephia AI |  $4,000,000  | (Nov 4, 2025)
                                                                        
                                Ornn |  $5,700,000  | (Nov 4, 2025)